Michael P. Thirlwell
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Esophageal Cancer Research and Treatment
Most-Cited Works
- → Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial(2018)229 cited
- → Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study.(1988)194 cited
- → Prevention and Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer: A Consensus Statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea(2007)160 cited
- → Randomized Trial of 3-Hour Versus 24-Hour Infusion of High-Dose Paclitaxel in Patients With Metastatic or Locally Advanced Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26(1999)155 cited
- → Hepatic malignancies: improved treatment with intraarterial Y-90.(1988)141 cited
- → Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients(1989)112 cited
- → Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial(2011)103 cited
- → Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial(2020)103 cited
- → Abstract S1-03: Primary results from BETH, a phase 3 controlled study of adjuvant chemotherapy and trastuzumab ± bevacizumab in patients with HER2-positive, node-positive or high risk node-negative breast cancer(2013)92 cited
- → Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain(1994)77 cited